![Shu Feng Zhang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shu Feng Zhang
Voorzitter bij Beijing Biostar Pharmaceuticals Co. Ltd.
Actieve functies van Shu Feng Zhang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Voorzitter | 01-03-2021 | - |
Directeur/Bestuurslid | 17-02-2016 | 01-03-2021 |
Loopbaan van Shu Feng Zhang
Opleiding van Shu Feng Zhang
Tsinghua University | Masters Business Admin |
Statistieken
Internationaal
China | 3 |
Operationeel
Masters Business Admin | 1 |
Director/Board Member | 1 |
Chairman | 1 |
Sectoraal
Consumer Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Health Technology |
- Beurs
- Insiders
- Shu Feng Zhang
- Ervaring